Evidence map›Paper›PMID 25232495›Full record

ArticleAmerican journal of cancer research2014

Activation of the Wnt pathway through Wnt2 promotes metastasis in pancreatic cancer.

Hua Jiang, Qingqing Li, Chengzhi He, Fengru Li, Haihui Sheng, Xiaoying Shen, Xiaoyan Zhang, Shizhang Zhu, Hui Chen, Ximei Chen and 2 more

Open access · greenAbstract read
In one paragraph

Article in American journal of cancer research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Unleashing Wnts: Wnt Ligands Fuel Cancer Spread.Journal of cancer biology · 2025
    Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Hua JiangDepartment of Gastroenterology, Shanghai East Hospital, Tongji University School of Medicine Shanghai 200120, China.
Qingqing LiDepartment of Gastroenterology, Shanghai East Hospital, Tongji University School of Medicine Shanghai 200120, China.
Chengzhi HeDepartment of Gastroenterology, Institute of Digestive Diseases, Tongji Hospital, Tongji University School of Medicine Shanghai 200065, China.
Fengru LiDepartment of Gastroenterology, Shanghai East Hospital, Tongji University School of Medicine Shanghai 200120, China.
Haihui ShengShanghai Engineering Center for Molecular Medicine, National Engineering Center for Biochip at Shanghai Shanghai, 201203, China.
Xiaoying ShenShanghai Engineering Center for Molecular Medicine, National Engineering Center for Biochip at Shanghai Shanghai, 201203, China.
Xiaoyan ZhangShanghai Engineering Center for Molecular Medicine, National Engineering Center for Biochip at Shanghai Shanghai, 201203, China.
Shizhang ZhuShanghai Engineering Center for Molecular Medicine, National Engineering Center for Biochip at Shanghai Shanghai, 201203, China.
Hui ChenShanghai Engineering Center for Molecular Medicine, National Engineering Center for Biochip at Shanghai Shanghai, 201203, China.
Ximei ChenDepartment of Gastroenterology, Institute of Digestive Diseases, Tongji Hospital, Tongji University School of Medicine Shanghai 200065, China.
Changqing YangDepartment of Gastroenterology, Institute of Digestive Diseases, Tongji Hospital, Tongji University School of Medicine Shanghai 200065, China.
Hengjun GaoDepartment of Gastroenterology, Institute of Digestive Diseases, Tongji Hospital, Tongji University School of Medicine Shanghai 200065, China ; Shanghai Engineering Center for Molecular Medicine, National Engineering Center for Biochip at Shanghai Shanghai, 201203, China.
National Engineering Research Center for Nanotechnology · CNTongji University · CNShanghai East Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Wnt signaling pathway plays an important role in physiological and pathological process, including in the occurrence and development of tumor. The purpose of this study is to determine whether Wnt2 and sFRP4, key molecules of signaling pathway, are of prognostic value for survival in patients with pancreatic cancer. We performed immunohistochemistry on tissue microarrays containing 90 pancreatic cancer specimens to evaluate the protein expression of Wnt2 and sFRP4. Our results showed that the cytoplasmic expression level of Wnt2 in pancreatic cancer tissues was significantly associated with LNM (P=0.029) and AJCC stage (P=0.008). Additionally, Kaplan-Meier analysis indicated that high Wnt2 expression was significantly correlated with poor clinical outcomes of patients with pancreatic cancer. In conclusion, Wnt2 may play an important role in the development of pancreatic cancer through activation of the Wnt pathways and serve as a potential candidate for treatment target of pancreatic cancer.

Indexed as

immunohistochemistryPancreatic cancersFRP4survival analysisWnt2Wnt signalling pathway

Identifiers

PMID25232495
PMCPMC4163618
OpenAlexW121009447

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.